Despite the outstanding methodology, this study will no doubt generate questions and debate, like most veteran studies, concerning sample representativeness and interpretation in the context of other research related to the Iraq and Afghanistan wars, PCL validity, or diagnostic changes between DSM-IV and DSM-5. Questions concerning representativeness stem from the observation that veterans account for > 9% of US adults (2010 census 5 ) but were identified in less than 4% of households in Wisco and colleagues' study sampling frame.1 Nevertheless, this remains one of the only national samples with a high response rate, and the demographic weighting using census figures increases the likelihood that results are nationally representative. Homeless veterans account for < 1% of US veterans and thus their absence from this sample would not significantly influence overall estimates.Current (1-month or 1-year) prevalence is generally more useful for projecting immediate health care requirements than lifetime prevalence, and studies over the last 10 years have been heavily focused on service members returning from Iraq or Afghanistan. However, these studies have produced current PTSD prevalence estimates ranging from < 5% to > 30%, 6,7 not useful for projecting health care needs. Such a wide range has been particularly notable when comparing UK and US personnel after Iraq or Afghanistan deployments, with prevalences in UK personnel consistently at the lowest end of the spectrum, though some US studies, such as the Millennium Cohort, 8 have produced similarly low estimates. Reasons for the striking differences across studies have been extensively debated, to include differences in demographics, exposure to combat, time between deployments, strategies in sampling, case criteria, level of anonymity of questionnaires, proportion of reservists to active members, and even the possibility of cultural differences.6,7 However, one meta-analysis 9 largely resolved this debate by showing that there is much greater consistency across studies than first recognized, provided that studies are suitably grouped. Studies involving stratified random sampling of all deployed personnel, including the large proportion in support roles (eg, UK and Millennium Cohort), yielded a weighted PTSD prevalence of 5.5% (95% CI, 5.4-5.6), comparable to nondeployed personnel, whereas the large body of research focused on combat infantry personnel (mostly US studies) yielded a weighted prevalence of 13.2% (95% CI, 12.8-13.7), 9 numbers nicely framing Wisco and colleagues' overall veteran estimate.